Terlipressin versus adrenaline in an infant animal model of asphyxial cardiac arrest.
OBJECTIVE
The objective of this study was to compare the efficacy of terlipressin versus adrenaline in an experimental infant animal model of asphyxial cardiac arrest (ACA).


METHODS
Prospective randomised animal study.


METHODS
Laboratory research department of a university hospital.


METHODS
Seventy-one, 2-month-old, mechanically ventilated piglets were investigated. ACA was induced by removal of mechanical ventilation. Resuscitation was performed by means of manual external chest compressions and mechanical ventilation (CC + V). After 3 min of CC + V, return of spontaneous circulation (ROSC) was observed in 11 animals. The 60 piglets without ROSC were then randomised to the four study groups: adrenaline standard dose (Asd): 0.01 mg/kg/3 min; adrenaline high dose (Ahd): first dose (0.01 mg/kg) and subsequent doses (0.1 mg/kg/3 min); terlipressin (T): 20 microg/kg/6 min; and adrenaline standard dose plus terlipressin (Asd + T).


RESULTS
The relationship between haemodynamic (heart rate, blood pressure, ECG rhythm, cardiac index), respiratory (end-tidal CO(2), blood gas analysis) and tissue perfusion (gastric intramucosal pH, central, cerebral and renal saturation) parameters and ROSC was analysed. ROSC was achieved in three piglets treated with Asd (20%), four treated with Ahd (26.7%), one treated with T (6.7%) and seven treated with Asd + T (46.7%) (P = 0.099). ROSC was achieved in 43.1% of animals with pulseless electrical activity, 30.4% with asystole and none with ventricular fibrillation (P = 0.0001).


CONCLUSIONS
In this infant animal model of cardiac arrest, there was a non-significant trend towards better outcome when terlipressin was combined with adrenaline compared with the use of adrenaline or terlipressin alone.
Pediatric Intensive Care Service, Hospital General Universitario Gregorio Marañón, Dr Castelo 47, 28009, Madrid, Spain. pielvi@ya.com
Jesús
J
López-Herce
Bárbara
B
Fernández
Javier
J
Urbano
Santiago
S
Mencía
Maria J
MJ
Solana
Jimena
J
del Castillo
Antonio
A
Rodríguez-Núñez
Jose M
JM
Bellón
D000818:Animals; D001237:Asphyxia / Q000150:complications / Q000188:drug therapy*; D016887:Cardiopulmonary Resuscitation / Q000379:methods; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D004837:Epinephrine / Q000494:pharmacology*; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology; D008236:Lypressin / Q000031:analogs & derivatives* / Q000494:pharmacology; D011446:Prospective Studies; D013552:Swine; D000077585:Terlipressin; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D014662:Vasoconstrictor Agents; D008236:Lypressin; D000077585:Terlipressin; D004837:Epinephrine